Evidence map›Paper›PMID 34499624›Full record

ArticleJCI insight2021

Epithelial stem cell homeostasis in Meibomian gland development, dysfunction, and dry eye disease.

Edem Tchegnon, Chung-Ping Liao, Elnaz Ghotbi, Tracey Shipman, Yong Wang, Renee M McKay, Lu Q Le

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Meibomian gland development: Where, when and how?Differentiation; research in biological diversity
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Edem TchegnonDepartment of Dermatology and.
Chung-Ping LiaoDepartment of Dermatology and.
Elnaz GhotbiDepartment of Dermatology and.
Tracey ShipmanDepartment of Dermatology and.
Yong WangDepartment of Dermatology and.
Renee M McKayDepartment of Dermatology and.
Lu Q LeDepartment of Dermatology and.
Center for Neuroscience and Regenerative Medicine · USTaipei Medical University · TWThe University of Texas Southwestern Medical Center · US

Funding

Transcriptional Function of Krox20 in Development and TumorigenesisR01CA166593 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI LE, LU · 2012 to 2022
$3.7M
Dermatology Research Training ProgramT32AR065969 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI PONCIANO D CRUZ, Tamia Alisha Harris-Tryon · 2014 to 2026
$1.6M
Epithelial stem cells in Meibomian gland development and homeostasisR01EY033344 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI Lu Le · 2022 to 2026
$1.6M
NCI NIH HHS R01 CA166593NEI NIH HHS R01 EY033344NIAMS NIH HHS T32 AR065969
6 · The paper itself

Abstract

Dry eye disease affects over 16 million adults in the US, and the majority of cases are due to Meibomian gland dysfunction. Unfortunately, the identity of the stem cells involved in Meibomian gland development and homeostasis is not well elucidated. Here, we report that loss of Krox20, a zinc finger transcription factor involved in the development of ectoderm-derived tissues, or deletion of KROX20-expressing epithelial cells disrupted Meibomian gland formation and homeostasis, leading to dry eye disease secondary to Meibomian gland dysfunction. Ablation of Krox20-lineage cells in adult mice also resulted in dry eye disease, implicating Krox20 in homeostasis of the mature Meibomian gland. Lineage-tracing and expression analyses revealed a restricted KROX20 expression pattern in the ductal areas of the Meibomian gland, although Krox20-lineage cells generate the full, mature Meibomian gland. This suggests that KROX20 marks a stem/progenitor cell population that differentiates to generate the entire Meibomian gland. Our Krox20 mouse models provide a powerful system that delineated the identity of stem cells required for Meibomian gland development and homeostasis and can be used to investigate the factors underlying these processes. They are also robust models of Meibomian gland dysfunction-related dry eye disease, with a potential for use in preclinical therapeutic screening.

Indexed as

AnimalsDry Eye SyndromesEpithelial CellsHomeostasisMeibomian Gland DysfunctionMiceStem CellsAdult stem cellsMouse modelsOphthalmology

Identifiers

PMID34499624
PMCPMC8564894
OpenAlexW3197444204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.